New NICE Guidelines on Sodium Valproate (November 2023)
Aims: The audit aims to ensure compliance with the new sodium valproate guidelines published in November 2023, identify areas of deviation from the guidelines, and improve patient safety and outcomes by promoting adherence to best practices.
Saved in:
| Main Authors: | Amany Elbagoury, Asif Zia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-06-01
|
| Series: | BJPsych Open |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2056472425105826/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the antinociceptive potential of sodium valproate in mice
by: Lidia Cristina Chitac, et al.
Published: (2014-06-01) -
Psoriasiform Drug Eruption Associated with Sodium Valproate
by: Gulen Gul Mert, et al.
Published: (2013-01-01) -
Cerebroprotective prevention of memory disorders using sodium valproate
by: A. V. Ivanov
Published: (2013-04-01) -
Patient Choice in Depression: Are We Failing to Implement NICE Guidelines?
by: Susan McPherson PhD, et al.
Published: (2025-04-01) -
Comparison of Functioning, Quality of Life, and Cognition between Lithium and Sodium Valproate Combination Therapy and Sodium Valproate Monotherapy in Euthymic Bipolar Patients: A Cross-sectional Study
by: M Ashwini, et al.
Published: (2025-01-01)